Abstract:The research described in this review briefly summarizes evidence that short term pharmacological enhancement of noradrenergic (NA) synaptic activity, combined with symptom relevant experience (SRE), promotes functional recovery of some symptoms of cortical damage in rat, cat and human beings even when treatment is initiated from days to weeks after injury. A summary is provided of the numerous drugs tested in rodent cortical injury models which have been proven useful for predicting beneficial or harmful effects on behavioral outcome in human stroke. The pattern of drug effects indicates a central role for NA in functional recovery. Additionally, studies of the effects of direct intraventricular infusion of monoamine neurotransmitters are reviewed and further support the hypothesized role of NA in recovery from some symptoms of cortical injury. The site of NA/SRE interaction to promote recovery from hemiplegia apparently involves the cerebellar hemisphere contralateral to the cortical injury. Microinfusions of NA into the contra- but not ipsilaterai cerebellar hemisphere dramatically enhance recovery. Furthermore, like its systemic action, microinfusion of the α 1 - NA receptor antagonist, phenoxybenzamine, reinstates hemiplegia. A “permanent” symptom of motor cortex injury in the cat is the complete loss of tactile placing contralateral to the injury which does not spontaneously recover for as long as seven years after ablation. This posturai reflex is temporarily restored for 8-12 hours following amphetamine administration. However, this permanently lost reflex can be enduringly restored by transplanting catecholamine secreting adrenal tissue into the wound cavity. The experiment is reviewed in detail and involves chromaffin cell autografts into the frontal cortex ablation wound cavity producing a restoration of tactile placing for the 7-10 month duration of the study. This enduring restoration of tactile placing is considered a result of the release of catecholamines into the CNS from the grafted chromaffin cells found, by histochemical methods, surviving 7-10 months after transplant. Lastly, we attribute these delayed treatment effects to an attenuation of a diaschisis, or remote functional depression, in morphologically intact areas anatomically connected to the area of injury. The widespread reduction of glycolytic and oxidative metabolism, produced by focal cortical injury, is normalized by the same treatment which alleviates symptoms and is worsened by drugs which exacerbate deficits. These data support the hypothesis that providing SRE during a period of enhanced NA synaptic activity produces an enduring functional recovery after cortical injury by attenuating remote functional depression. This treatment for enhancing recovery is especially attractive since it is effective even when begun weeks after cortical damage.

Noradrenaline-Dependent And Time-Dependent Changes In Neocortical Alpha-2-And Beta-1-Adrenoceptor Binding In Dorsal Noradrenergic Bundle-Lesioned Rats

Telencephalic but Not Diencephalic Noradrenaline Depletion Enhances Behavioural but Not Endocrine Measures of Fear Conditioning to Contextual Stimuli

Effects of Lesions to Ascending Noradrenergic Neurones on Performance of a 5-Choice Serial Reaction Task in Rats; Implications for Theories of Dorsal Noradrenergic Bundle Function Based on Selective Attention and Arousal

Forebrain Norepinephrine - Role In Controlled Information-Processing In The Rat

Lesions of the Dorsal Noradrenergic Bundle Impair Attentional Set-Shifting in the Rat

Amphetamine Impairs the Discriminative Performance of Rats with Dorsal Noradrenergic Bundle Lesions on a 5-Choice Serial Reaction Time Task: New Evidence for Central Dopaminergic-Noradrenergic Interactions.

Diencephalic Noradrenaline Depletion Impairs the Corticosterone Response to Footshock but Does Not Affect Conditioned Fear

Enhanced Behavioral Conditioning to Context and Impaired Behavioral and Neuroendocrine Responses to Conditioned Stimuli Following Ceruleocortical Noradrenergic Lesions: Support for an Attentional Hypothesis of Central Noradrenergic Function.

Dissociable Effects of Lesions to the Dorsal or Ventral Noradrenergic Bundle on the Acquisition, Performance, and Extinction of Aversive Conditioning.

Changes in Body Weight and Food-Related Behaviour Induced by Destruction of the Ventral or Dorsal Noradrenergic Bundle in the Rat

Noradrenaline and Conditioned Reinforcement.

Selective Noradrenaline Depletion in the Neocortex and Hippocampus Induces Working Memory Deficits and Regional Occurrence of Pathological Proteins

Comparative Functions of the Central Noradrenergic, Dopaminergic and Cholinergic Systems.

Damage to Ceruleo-Cortical Noradrenergic Projections Impairs Locally Cued but Enhances Spatially Cued Water Maze Acquisition

In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus

Noradrenergic Pharmacotherapy, Intracerebral Infusion and Adrenal Transplantation Promote Functional Recovery After Cortical Damage

Differential Effects of Mesocortical, Mesolimbic, and Mesostriatal Dopamine Depletion on Spontaneous, Conditioned, and Drug-Induced Locomotor Activity

Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats

Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation

Effects of Lesions of the Nucleus Basalis Magnocellularis on the Acquisition of Cocaine Self-Administration in Rats

Effects of 6-Hydroxydopamine Lesions of the Nucleus Accumbens Septi on Performance of a 5-Choice Serial Reaction Time Task in Rats: Implications for Theories of Selective Attention and Arousal